Description:
The International Journal of Systems Biology and Biomedical Technologies (IJSBBT) explores the scientific foundations involved in Systems Biology and advanced engineering models for Biomedical Technology development. The journal covers a variety of disciplines ranging from the biological and the... Show More
The International Journal of Systems Biology and Biomedical Technologies (IJSBBT) explores the scientific foundations involved in Systems Biology and advanced engineering models for Biomedical Technology development. The journal covers a variety of disciplines ranging from the biological and the mathematical foundations of Systems Biology to artificial life and bioengineering. The International Journal of Systems Biology and Biomedical Technologies (IJSBBT) presents original research in all levels of Systems Biology applications linked to telemedicine, electronic healthcare, in addition to Biomedical Technologies and the general promotion of healthcare.
Mission & Scope:
The mission of the International Journal of Systems Biology and Biomedical Technologies (IJSBBT) is to systematically investigate the convergence of Systems Biology and Biomedical Technologies and serve as an interdisciplinary forum for international debate on theoretical and practical aspects of these fields. In this endeavor, the journal promotes cutting-edge research and best practices in... Show More
The mission of the International Journal of Systems Biology and Biomedical Technologies (IJSBBT) is to systematically investigate the convergence of Systems Biology and Biomedical Technologies and serve as an interdisciplinary forum for international debate on theoretical and practical aspects of these fields. In this endeavor, the journal promotes cutting-edge research and best practices in Systems Biology and Biomedical Technologies.
Coverage:
- Artificial Life
- Biobanks and registries
- Biodefense information systems
- Bioengineering
- Bioethics
- Biological computing and biorobotics
- Biomathematics and biometry
- Biomedical information integration modelling
- Biostatistics
- Biotechnology
- Data and literature mining
- Genetic Engineering
- Interoperability and standards
- Omics and electronic healthcare
- Omics and telemedicine
- Omics information processing
- Patient security and privacy
- Pharmacogenomics and pharmacovigilance
- Smart biomedical device development
- Systems biology and anti-aging
- Systems biology and cognitive science
- Systems biology and disease informatics
- Systems biology and environmental health
- Systems biology and genome epidemiology
- Systems biology and nanobiotechnology
- Systems biology and public health informatics
- Systems biology and tissue and organ informatics
- Systems biology in molecular informatics
IGI Global holds its journals to the highest ethical practices.
View Full Editorial PolicyAs this journal is under the Hybrid Open Access model, authors can choose between Standard (Non-OA) publishing or Open Access publishing. Find the policies for the publishing models below:
- Standard (Non-OA) Publishing: If the author chooses to publish under the Standard (Non-OA) model, the article will be published under a Green OA model and the copyright of
their article will transfer to IGI Global under our Author Warranty and Transfer of Copyright Agreement.
However, through Green OA, IGI Global supports a Fair Use Policy, enabling authors to Post the final
typeset PDF (which includes the title page, table of contents and other front materials, and the copyright
statement) of their chapter or article (NOT THE ENTIRE BOOK OR JOURNAL ISSUE), on the author or
editor's secure personal website and/or their university repository site. See the Fair Use Policy for sharing allowances conducive to Green Open Access.
- Open Access Publishing: If the author choses to publish under OA, the authors receive the
Creative Commons Attribution 4.0 International (CC BY 4.0) licensing arrangement. The copyright for the
work remains solely with the author(s) of the article. Others may distribute, remix, tweak, and build upon
the work, even commercially, without asking prior permission from the publisher or author and so long as
they credit the author for the original creation. All authors are required to sign an author's warranty
stating that the materials are original and unpublished elsewhere. The journal will not publish any
material that has been previously published elsewhere. Learn More
This journal operates under the Hybrid Open Access model,
allowing the author to choose between traditional, subscription-based publishing, or Open Access publishing.
Subscription-Based Publishing/Green Open Access:
Article manuscripts require no Article Processing Charge (APC) and require authors to transfer the copyright of the
manuscript to IGI Global. Manuscripts are published behind a paywall and must be purchased for use. See the
Fair Use Policy
for sharing allowances conducive to Green Open Access.
Open Access Publishing:
Article manuscripts receive the Creative Commons Attribution 4.0 International
(CC BY 4.0) licensing arrangement. The copyright for the work remains solely with the author(s) of
the article. Others may distribute, remix, tweak, and build upon the work, even commercially, without asking
prior permission from the publisher or author and so long as they credit the author for the original creation.
A one-time Article Processing Charge (APC) of US $2,300 must be paid AFTER the manuscript has gone
through the full double-blind peer review process and the Editor(s)-in-Chief at his/her/their full discretion
has decided to accept the manuscript based on the results of the double-blind peer review process. Learn
more about APCs
here.
Open Access Funding:
IGI Global recognizes that many researchers may not know where to begin when searching for OA funding opportunities. IGI Global recently
launched an
Open Access Funding Resources
page for researchers to browse. This page provides a comprehensive list of OA funding sources available for researchers to secure funds
for their various OA publications.
Author Services Inquiries
For inquiries involving pre-submission concerns, please contact the Journal Development Division:
journaleditor@igi-global.comOpen Access Inquiries
For inquiries involving publishing costs, APCs, etc., please contact the Open Access Division:
openaccessadmin@igi-global.comProduction-Related Inquiries
For inquiries involving accepted manuscripts currently in production or post-production, please contact the Journal Production Division:
journalproofing@igi-global.comRights and Permissions Inquiries
For inquiries involving permissions, rights, and reuse, please contact the Intellectual Property & Contracts Division:
contracts@igi-global.comPublication-Related Inquiries
For inquiries involving journal publishing, please contact the Acquisitions Division:
acquisition@igi-global.comDiscoverability Inquiries
For inquiries involving sharing, promoting, and indexing of manuscripts, please contact the Citation Metrics & Indexing Division:
indexing@igi-global.com Editorial Office
701 E. Chocolate Ave.
Hershey, PA 17033, USA
717-533-8845 x100
The International Journal of Systems Biology and Biomedical Technologies (IJSBBT) is owned and published by IGI Global.
International Journal of Systems Biology and Biomedical Technologies (IJSBBT) is editorially independent, with full authority of the journal's content falling to the Editor-in-Chief and the journal's
Editorial Board.
The In-House Editorial Office manages the publishing operations of the journal.
IGI Global
701 East Chocolate Avenue
Hershey, PA 17033
USA
Principal Contact
Grace Long
Managing Editor of Journal Development
IGI Global
Phone: (717) 533-8845 ext. 147
E-mail: glong@igi-global.com
Support Contact
Jaimie Watts
Development Editor - International Journal of Systems Biology and Biomedical Technologies (IJSBBT)
IGI Global
Phone: 717-533-8845
E-mail:
Reviews and Testimonials
Today, huge amounts of diverse data are generated in multiple research domains throughout the whole extent of biomedicine (-omics, biosignals, biomedical images), from the bedside to experimental laboratories, adding new factors that should be considered in medical decision making. Although medical professionals can now have access to more information on their patients' conditions, such data also complicate their work, setting new challenges regarding their efficient processing, interpretation and integration through innovative computational approaches. Sophisticated computer modeling tools are essential to compare observations of an individual patient and relate them to a vast dataset of observations of others with similar symptoms and known conditions. Integrated and individualized biomedical data sources along with advanced information and communication tools will need to make a significant contribution to translational research, namely the movement of discoveries from the bench to bedside, toward the ultimate goal of personalized medicine. Such tools will not only contribute in delivering effective therapies, tailored to the exact biological state of an individual, but could also be used in preventive medicine, to predict occurrence or evolution of specific diseases in people at risk. The International Journal of Systems Biology and Biomedical Technology provides a unique venue for the publication of groundbreaking work in these emerging topics that hold the promise toward personalized healthcare solutions.
– Nantia Nikita, National Technical University of Athens, Greece